Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00576147 · ClinicalTrials.gov registry record · NA

A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection

A NA study of TBI (Traumatic Brain Injury), sponsored by InfraScan.

Completed
Registry status
NA
Development phase
431
Enrollment target
4
Study locations

NCT00576147 is a NA study of TBI (Traumatic Brain Injury) that has completed, run by InfraScan. The registered enrollment target is 431 participants, above the 152-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (184% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00576147, a NA study of TBI (Traumatic Brain Injury), has completed, sponsored by InfraScan.

COMPLETED
Registry status
NA
Development phase
431 participants
Enrollment target
4
Study locations

Study Summary

The purposes of this study are: 1. To determine the sensitivity and specificity of the Near-Infrared Spectroscopy (NIRS) measurements for identifying intracranial hematomas due to trauma. 2. To determine the reproducibility of the Near-Infrared Spectroscopy (NIRS) measurements with different operators and at different centers

Interventions

  • DEVICE Infrascanner

Study Locations (4)

Maryland

  • Johns Hopkins University - Baltimore

Ohio

  • University of Cincinnati - Cincinnati

Pennsylvania

  • The Hospital of the University of Pennsylvania - Philadelphia

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 431 participants
Start Date 2006-07
Est. Completion 2011-01
Phase NA

Sponsor

InfraScan

2 total trials

What the Registry Record Tells You About NCT00576147

The ClinicalTrials.gov registry entry for NCT00576147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 431 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 152-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (184% higher). The listed sponsor is InfraScan, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 1 intervention - of which Infrascanner is the first listed.

NCT00576147 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Maryland, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00576147 about?

NCT00576147 is a clinical study titled "A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection". The purposes of this study are: 1. To determine the sensitivity and specificity of the Near-Infrared Spectroscopy (NIRS) measurements for identifying intracranial hematomas due to trauma. 2. To determine the reproducibility of the Near-Infrared Spectroscopy (NIRS) measurements with different operat...

What is the current status of trial NCT00576147?

This trial is currently completed. It is a NA study. The enrollment target is 431 participants. The study started on 2006-07. Estimated completion is 2011-01.

What conditions does trial NCT00576147 study?

This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).

What interventions are being tested in trial NCT00576147?

The interventions under investigation include: Infrascanner (DEVICE).

Who is sponsoring clinical trial NCT00576147?

This trial is sponsored by InfraScan, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00576147 being conducted?

This trial has 4 study locations across Maryland, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for TBI (Traumatic Brain Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.